EUVIMEDEUVIMED entdecken
Open Access

Promising Practices Observed in High-Throughput COVID-19 Vaccination Sites in the United States, February–May 2021

Caitlin E McColloch, Marsha E Samson, KaeAnne Parris, Amy Stewart, Judith A Robinson, Barbara Cooper, Eboni Galloway, Robert Garcia, Zunera Gilani, Bina Jayapaul-Philip, Paul Lucas, Kimberly H Nguyen und 3 weitere

American Journal of Public Health · 2023

DOI: 10.2105/ajph.2023.307331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Public Health, 2023. Verfasst von Caitlin E McColloch und 14 weiteren Autor:innen. Beteiligte Einrichtung: All authors are with the COVID-19 Response's Vaccine Task Force, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Hauptthemen laut MEDLINE: COVID-19, Influenza Vaccines, Influenza, Human. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To identify promising practices for implementing COVID-19 vaccination sites.

Methods

The Centers for Disease Control and Prevention (CDC) and Federal Emergency Management Agency (FEMA) assessed high-throughput COVID-19 vaccination sites across the United States, including Puerto Rico, after COVID-19 vaccinations began. Site assessors conducted site observations and interviews with site staff. Qualitative data were compiled and thematically analyzed.

Results

CDC and FEMA conducted 134 assessments of high-throughput vaccination sites in 25 states and Puerto Rico from February 12 to May 28, 2021. Promising practices were identified across facility, clinical, and cross-cutting operational areas and related to 6 main themes: addressing health equity, leveraging partnerships, optimizing site design and flow, communicating through visual cues, using quick response codes, and prioritizing risk management and quality control.

Conclusions

These practices might help planning and implementation of future vaccination operations for COVID-19, influenza, and other vaccine-preventable diseases. Public Health Implications. These practices can be considered by vaccination planners and providers to strengthen their vaccination site plans and implementation of future high-throughput vaccination sites. (Am J Public Health. 2023;113(8):909–918. https://doi.org/10.2105/AJPH.2023.307331 )

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Influenza VaccinesInfluenza, HumanHumansUnited StatesCOVID-19 VaccinesVaccination

Substanzen

COVID-19 VaccinesInfluenza Vaccines

Autor:innen und Institutionen

  • All authors are with the COVID-19 Response's Vaccine Task Force, Centers for Disease Control and Prevention (CDC), Atlanta, GA.

Zitieren

APA

McColloch, C. E., Samson, M. E., Parris, K., Stewart, A., Robinson, J. A., Cooper, B., Galloway, E., Garcia, R., Gilani, Z., Jayapaul-Philip, B., Lucas, P., Nguyen, K. H., Noe, R. S., Trudeau, A. T., & Kennedy, E. D. (2023). Promising Practices Observed in High-Throughput COVID-19 Vaccination Sites in the United States, February–May 2021. American Journal of Public Health. https://doi.org/10.2105/ajph.2023.307331

Vancouver

McColloch CE, Samson ME, Parris K, Stewart A, Robinson JA, Cooper B, et al. Promising Practices Observed in High-Throughput COVID-19 Vaccination Sites in the United States, February–May 2021. American Journal of Public Health. 2023. doi:10.2105/ajph.2023.307331

BibTeX
@article{McColloch2023,
  author = {McColloch, Caitlin E and Samson, Marsha E and Parris, KaeAnne and Stewart, Amy and Robinson, Judith A and Cooper, Barbara and Galloway, Eboni and Garcia, Robert and Gilani, Zunera and Jayapaul-Philip, Bina and Lucas, Paul and Nguyen, Kimberly H and Noe, Rebecca S and Trudeau, Aimée-Rika T and Kennedy, Erin D},
  title = {Promising Practices Observed in High-Throughput COVID-19 Vaccination Sites in the United States, February–May 2021},
  journal = {American Journal of Public Health},
  year = {2023},
  doi = {10.2105/ajph.2023.307331}
}
Kostenlos starten →